Application in Particular Diseases
ChemicalBook > CAS DataBase List > CYCLOSPORINE

CYCLOSPORINE

Application in Particular Diseases
Product Name
CYCLOSPORINE
CAS No.
79217-60-0
Chemical Name
CYCLOSPORINE
Synonyms
CNP (1-22);CYCLOSPORIN;CYCLOSPRINE;Cyclosporins;Cyclosporine;Cyclosporine (Neoral);CYCLOSPORINE USP/EP/BP;79217-60-0 CYCLOSPORINE;Cyclosporine (NSC-290193);CYCLOSPORINE / CICLOSPORIN
CBNumber
CB1150021
Molecular Formula
C62H111N11O12
Formula Weight
1202.61
MOL File
79217-60-0.mol
More
Less

CYCLOSPORINE Property

form 
Solid
color 
White to light yellow
BCS Class
2,3,4
CAS DataBase Reference
79217-60-0(CAS DataBase Reference)
IARC
1 (Vol. 50, 100A) 2012
More
Less

Hazard and Precautionary Statements (GHS)

More
Less

N-Bromosuccinimide Price

AK Scientific
Product number
Q333
Product name
Cyclosporine
Packaging
5mg
Price
$20
Updated
2021/12/16
AK Scientific
Product number
Q333
Product name
Cyclosporine
Packaging
10mg
Price
$30
Updated
2021/12/16
Biosynth Carbosynth
Product number
FC31886
Product name
Cyclosporine
Packaging
50mg
Price
$50
Updated
2021/12/16
Biosynth Carbosynth
Product number
FC31886
Product name
Cyclosporine
Packaging
100mg
Price
$80
Updated
2021/12/16
Biosynth Carbosynth
Product number
FC31886
Product name
Cyclosporine
Packaging
250mg
Price
$150
Updated
2021/12/16
More
Less

CYCLOSPORINE Chemical Properties,Usage,Production

Application in Particular Diseases

In Rheumatic Arthritis:
Cyclosporine reduces production of cytokines involved in T-cell activation and has direct effects on B cells, macrophages, bone, and cartilage cells. Its onset appears to be 1 to 3 months. Important toxicities at doses of 1 to 10 mg/kg/day include hypertension, hyperglycemia, nephrotoxicity, tremor, GI intolerance, hirsutism, and gingival hyperplasia. Cyclosporine should be reserved for patients refractory to or intolerant of other DMARDs. It should be avoided in patients with current or past malignancy, uncontrolled hypertension, renal dysfunction, immunodeficiency, low white blood cell or platelet counts, or elevated liver function tests.

Description

Cyclosporine is a cyclic polypeptide with potent, partially selective immunosupressive activity. Isolated from the species Cylindrocarpon lucidium and Trichoderma polysporum, cyclosporine is useful in the prevention and treatment of graft/host disease and the prevention of rejection following organ transplantation. It appears to act by preferentially suppressing T-lymphocytes. Cyclosporine lacks myelotoxicity, although impaired renal and liver function have been observed. Initial administration is via the intravenous route, followed by oral maintenance therapy.

Chemical Properties

White crystalline solid or powder.

Originator

Sandoz (Switzerland)

Indications

Cyclosporine (Sandimmune) is a potent inhibitor of antibody- and cell-mediated immune responses and is the immunosuppressant of choice for the prevention of transplant rejection. It also has application in the treatment of autoimmune diseases.
Cyclosporine is a highly stable 11-amino acid cyclic polypeptide. The molecule is very lipophilic and essentially is not soluble in water. It can be administered intravenously, orally, or by injection.

brand name

SANDIMMUN

Mechanism of action

Cyclosporine can bind to the cytosolic protein cytophilin C. This drug–protein complex inhibits calcineurin phosphatase activity, which leads to a decreased synthesis and release of several cytokines, including interleukins IL-2, IL-3, IL-4, interferon-, and tumor necrosis factor.
Cyclosporine exhibits a high degree of specificity in its actions on T cells without significantly impairing Bcell activity. It can inhibit the T cell–dependent limb of antibody production by lymphocytes by preventing the differentiation of B cells into antibody-secreting plasma cells. Because T cells appear to require IL-2 stimulation for their continuous growth, cyclosporine impairs the proliferative response of T cells to antigens. However, once T cells have been stimulated by antigens to synthesize IL-2, cyclosporine cannot suppress the proliferation of T cells induced by this cytokine.

Pharmacology

After oral administration, cyclosporine is absorbed slowly and incompletely, with great variation among individuals. Peak plasma concentrations are reached in 3 to 4 hours, and the plasma half-life is 10 to 27 hours. The drug is extensively metabolized by hepatic mixedfunction oxidase enzymes and is excreted principally via the bile into the feces. Metabolism results in inactivation of the immunosuppressive activity.Agents that enhance or inhibit the mixed-function oxidase enzymes will alter the therapeutic response to cyclosporine.

Clinical Use

Cyclosporine has been approved for use in allogeneic kidney, liver, and heart transplant patients and is under study for use in pancreas, bone marrow, single lung, and heart–lung transplant procedures. It is recommended that corticosteroids, such as prednisone, be used concomitantly, although at half or less of their usual dose. Such combined therapy leads to fewer side effects, a decreased incidence of infectious complications, efficacy of lower doses of cyclosporine, and a better history of patient survival.
Cyclosporine appears to have promise in the treatment of autoimmune diseases. It has a beneficial effect on the course of rheumatoid arthritis, uveitis, insulindependent diabetes, systemic lupus erythematosus, and psoriatic arthropathies in some patients. Toxicity is more of a problem in these conditions than during use in transplantation, since higher doses of cyclosporine are often required to suppress autoimmune disorders.

Side effects

Compared with previously available therapy, the adverse effects associated with cyclosporine are much less severe but still worthy of concern. Nephrotoxicity, which can occur in up to 75% of patients, ranges from severe tubular necrosis to chronic interstitial nephropathy.This effect is generally reversible with dosage reduction. Vasoconstriction appears to be an important aspect of cyclosporine- induced nephrotoxicity. Hypertension occurs in 25% of the patients and more frequently in patients with some degree of renal dysfunction; the concomitant use of antihypertensive drugs may prove useful. Hyperglycemia, hyperlipidemia, transient liver dysfunction, and unwanted hair growth are also observed.

Potential Exposure

Cyclosporin A is a fungal metabolite; an amide immunosuppressant drug used in various surgeries.

Veterinary Drugs and Treatments

Cyclosporine may be useful as an immunosuppressant for immunemediated diseases (see dosage section) and as part of a protocol to reduce the rejection of allografts in transplant medicine in dogs and cats.

Shipping

UN3249 Medicine, solid, toxic, n.o.s., Hazard Class: 6.1; Labels: 6.1-Poisonous materials.

Incompatibilities

Amides/imides react with azo and diazo compounds to generate toxic gases. Flammable gases are formed by the reaction of organic amides/imides with strong reducing agents such as hydrideds and active metals. Amides are very weak bases (weaker than water). Imides are less basic yet and in fact react with strong bases to form salts. That is, they can react as acids. Mixing amides with dehydrating agents such as such as phosphorus pent- oxide or thionyl chloride generates the corresponding nitrile. The combustion of these compounds generates mixed oxides of nitrogen (NOx).

Waste Disposal

t is inappropriate and possibly dangerous to the environment to dispose of expired or waste drugs and pharmaceuticals by flushing them down the toilet or discarding them to the trash. Household quantities of expired or waste pharmaceuticals may be mixed with wet cat litter or coffee grounds, double-bagged in plastic, discard in trash. Larger quantities shall carefully take into consider- ation applicable DEA, EPA, and FDA regulations. If possi- ble return the pharmaceutical to the manufacturer for proper disposal being careful to properly label and securely package the material. Alternatively, the waste pharmaceutical shall be labeled, securely packaged, and transported by a state licensed medical waste contractor to dispose by burial in a licensed hazardous or toxic waste landfill or incinerator.

CYCLOSPORINE Preparation Products And Raw materials

Raw materials

Preparation Products

More
Less

CYCLOSPORINE Suppliers

Pure Chemistry Scientific Inc.
Tel
001-857-928-2050 or 1-888-588-9418
Fax
001-617-206-9595
Email
sales@chemreagents.com
Country
United States
ProdList
10186
Advantage
62
LGM Pharma
Tel
1-(800)-881-8210
Fax
615-250-9817
Email
inquiries@lgmpharma.com
Country
United States
ProdList
2123
Advantage
70
BOC Sciences
Tel
1-631-485-4226; 16314854226
Email
info@bocsci.com
Country
United States
ProdList
14055
Advantage
65
BOC Sciences
Tel
16314854226
Email
info@bocsci.com
Country
United States
ProdList
9923
Advantage
65
Target molecule Corp.
Tel
857-239-0968
Fax
857-239-8801
Email
service1@targetmol.com
Country
United States
ProdList
2559
Advantage
60
TargetMol Chemicals Inc.
Tel
+1-781-999-5354 +1-00000000000
Email
marketing@targetmol.com
Country
United States
ProdList
32165
Advantage
58
Aladdin Scientific
Tel
+1-+1(833)-552-7181
Email
sales@aladdinsci.com
Country
United States
ProdList
57505
Advantage
58
TargetMol Chemicals Inc.
Tel
Email
support@targetmol.com
Country
United States
ProdList
38632
Advantage
58
AlliChem, LLC
Tel
--
Fax
--
Email
sales@allichemllc.com
Country
United States
ProdList
6516
Advantage
60
Beta Pharma, Inc.
Tel
--
Fax
--
Email
sales@betapharma.com
Country
United States
ProdList
6226
Advantage
60
Waterstone Technology, LLC
Tel
--
Fax
--
Email
sales@waterstonetech.com
Country
United States
ProdList
6786
Advantage
30
LC Laboratories
Tel
--
Fax
--
Email
custserv@lclabs.com
Country
United States
ProdList
503
Advantage
50
United States Biological
Tel
--
Fax
--
Email
chemicals@usbio.net
Country
United States
ProdList
6214
Advantage
80
ABBVIE INC
Tel
--
Fax
--
Email
customerservice@abbvie.com
Country
United States
ProdList
7
Advantage
58
CHEMWERTH INC
Tel
--
Fax
--
Email
sales@chemwerth.com
Country
United States
ProdList
56
Advantage
58
2A PharmaChem USA
Tel
--
Fax
--
Email
sales@2apharmachem.com
Country
United States
ProdList
6137
Advantage
39
Santa Cruz Biotechnology, Inc.
Tel
--
Fax
--
Email
scbt@scbt.com
Country
United States
ProdList
3597
Advantage
60
ACIC Fine Chemicals Inc.
Tel
--
Fax
--
Email
sales@acic.com
Country
United States
ProdList
492
Advantage
48
3B Scientific Corporation
Tel
--
Fax
--
Email
sales@3bsc.com
Country
United States
ProdList
6718
Advantage
47
AK Scientific, Inc.
Tel
--
Fax
--
Email
sales@aksci.com
Country
United States
ProdList
6347
Advantage
65
APAC Pharmaceutical, LLC
Tel
--
Fax
--
Email
sales@apacpharma.com
Country
United States
ProdList
6322
Advantage
38
Aceto Corporation
Tel
--
Fax
--
Email
contact@aceto.com
Country
United States
ProdList
2619
Advantage
75
Ivy Fine Chemicals
Tel
--
Fax
--
Email
sales@ivychem.com
Country
United States
ProdList
6493
Advantage
58
BOSCHE SCIENTIFIC, LLC
Tel
--
Fax
--
Email
Sales@BoscheSci.com
Country
United States
ProdList
6477
Advantage
55
ChemPacific Corporation
Tel
--
Fax
--
Email
sales@chempacific.com
Country
United States
ProdList
6891
Advantage
51
XENOS Bioresources, Inc.
Tel
--
Fax
--
Email
xenos@west.net
Country
United States
ProdList
122
Advantage
38
More
Less

View Lastest Price from CYCLOSPORINE manufacturers

Hebei Chuanghai Biotechnology Co,.LTD
Product
Cyclosporine 79217-60-0
Price
US $1.90/KG
Min. Order
1KG
Purity
99%
Supply Ability
10 ton
Release date
2024-08-20
WUHAN CIRCLE POWDER TECHNOLOGY CO.,LTD
Product
Cyclosporine 79217-60-0
Price
US $0.00/KG
Min. Order
100g
Purity
98%+
Supply Ability
100kg
Release date
2020-11-05
Guangzhou Biocar Biotechnology Co.,Ltd.
Product
CYCLOSPORINE 79217-60-0
Price
US $1.00/g
Min. Order
10g
Purity
99.5%
Supply Ability
1000kg
Release date
2022-01-19

79217-60-0, CYCLOSPORINERelated Search:


  • CYCLOSPORIN
  • Cyclosporin A / B / C / D / H A 59865-13-3 /
  • Cyclosporins
  • CYCLOSPRINE
  • CYCLOSPORINE / CICLOSPORIN
  • Cyclosporine
  • Cyclosporine (Neoral)
  • Cyclosporine (cyclosporin A)
  • CYCLOSPORINE USP/EP/BP
  • Cyclosporine DISCONTINUED. Please see C988900.
  • 79217-60-0 CYCLOSPORINE
  • CNP (1-22)
  • C-Type Natriuretic Peptide (CNP) (1-22)
  • Cyclosporine (NSC-290193)
  • 79217-60-0
  • Inhibitors
  • API